GI surgical sealant receives CE marking for sale in the EU — 5 insights

Sealantis, the Haifa, Israel-based developer of absorbable surgical sealants and adhesives, received CE marking approval for its Seal-G Surgical Sealant. The CE marking will allow the product to be marketed in Europe and other countries.

Advertisement

Here is what you should know:

 

1. It is the only alginate sealant designed specifically to reduce leaks after GI surgery.

 

2. Sealantis uses a protein-free plant-based technology which provides strong adhesion in a wet surgical field. Seal-G is the company’s flagship product and is engineered to reinforce the staple-line or suture in GI surgery.

 

3. Seal-G prevents anastomotic leaks, a complication that occurs in 5 percent to 15 percent of GI surgical patients, by reinforcing the anastomosis in the initial postsurgery period when leaks are most likely to occur.

 

4. Anastomotic leaks cause one-third of postsurgical deaths after colorectal surgery, and this devastating complication can increase patient management costs fivefold.

 

5. Seal-G is not approved by the FDA and is not yet available for sale in the United States.

 

More articles on gastroenterology:

GI leader to know: Dr. Donnie Smith of GI Associates of West Alabama

Motus GI files for $29M initial public offering — 3 insights

Top 10 states with the highest volume of gastroenterology procedures per ASC

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.